Umbilical Cord Tissue Banking
What is Cord Tissue Banking and Cryo-Cell’s Cord Tissue Banking service?
Cryo-Cell proudly introduces our advanced new cord tissue banking service, which stores a section of the umbilical cord tissue. Approximately six inches of the cord tissue is procured and transported to Cryo-Cell’s state-of-the-art laboratory for processing, testing and cryopreservation for potential future use. Umbilical cord tissue banking is beneficial beause the tissue contains a rich source of mesenchymal stem cells (MSCs), which are increasingly being utilized in regenerative medicine research, targeting potential therapies for a wide range of conditions including heart disease, stroke, multiple sclerosis and diabetes.
What is the difference between Umbilical Cord Blood Stem Cells and Cord Tissue Stem Cells?
Umbilical cord blood is the blood that remains in the vein of the umbilical cord and placenta at the time of birth. This blood is rich in hematopoietic or blood derived stem cells. The cord tissue or Wharton’s jelly is the tissue surrounding the umbilical vein and vessels in the cord. When the vessels are removed, you have tissue remaining which contains stem cells termed mesenchymal stem cells. The mesenchymal stem cells have the capability to differentiate into bone cells, fat cells and cartilage.
Banking cord tissue stem cells now can be your protection for future medical uses.
Are Mesenchymal Stem Cells used in Therapeutic Treatments?
Mesenchymal stem cells from several different tissues are being tested in clinical trials for efficacy. Specifically, cells derived from cord tissue are currently being used in many clinical trials; for example treating cardiomyopathy, ulcerative colitis, diabetes, anemia, autism and cirrhosis of the liver. Cord blood tissue banking is your investment in future potential medical uses. For more information on these clinical trials you may log on to
http://clinicaltrials.gov.
Click here for Cord Blood/Cord Tissue Brochure
Cryo-Cell’s umbilical cord tissue banking service provides expectant families with the opportunity to cryogenically store their newborn’s umbilical cord tissue cells contained within substantially intact cord tissue. Should umbilical cord tissue cells be considered for potential utilization in a future therapeutic application, further laboratory processing will be required.
Cryo-Cell’s activities for New York State residents are limited to collection, processing, and long-term storage of umbilical cord tissue stem cells. Cryo-Cell’s possession of a New York State license for such collection, processing, and long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.